Salesforce is Nearly Fully Priced: Why Bulls Say This is Just the Beginning
Salesforce bulls are pointing to an AI monetization curve that is bending sharply upward, but the bears have real ammunition too, and with Dreamforce and Investor Day arriving next week, the stock sits at a crossroads where the next few…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
At $249.12, Salesforce (NYSE:CRM | CRM Price Prediction) screens attractively. The stock looks fully priced on trailing numbers, yet the AI monetization curve underneath it is bending sharply upward, and the setup into Dreamforce and the September 16, 2026 Investor Day gives bulls a near-term catalyst the market has not fully absorbed.
Salesforce is the world’s largest customer relationship management software company, and it has spent the past year retooling itself around agentic AI. Fiscal 2026 revenue reached $41.53 billion, and management is guiding fiscal 2027 to $46.10 billion to $46.40 billion, with a stated $63 billion FY30 target. The stock, however, has lagged. Shares are down 5.47% year to date even after a 29.25% one-month surge tied to the Q2 report.
Why the Agentforce Ramp Changes the Math
The bull argument starts with AI traction that is no longer theoretical. Agentforce ARR crossed $1.5 billion, up over 240% year over year, and combined Agentforce plus Data 360 ARR reached roughly $3.9 billion, up more than 210%. Q2 delivered revenue of $11.35 billion, up 10.83%, and a sixth straight EPS beat.
Valuation looks reasonable against that growth. Shares trade at roughly 27x trailing earnings with a 7.02% free cash flow yield. The $25 billion accelerated buyback took diluted shares to 821 million from 962 million, and cRPO grew 14% to $33.5 billion, a leading indicator that the second-half reacceleration is real.
Where the Bear Thesis Has Real Teeth
Skeptics can point to genuine cracks. Q2 non-GAAP EPS of $5.90 was flattered by $2.53 per share in strategic investment gains, and operating income fell 0.04% year over year despite double-digit revenue growth. Free cash flow guidance of only 4% to 5% growth undercuts the AI hyper-growth story.
The balance sheet has changed too. Noncurrent debt jumped to $39.3 billion from $10.4 billion to fund the ASR, total liabilities rose 96.56%, and shareholders’ equity fell 37.42%. Bears argue the buyback is manufacturing EPS while operating leverage stalls.
Why Some Investors Are Still Waiting
The Hold case rests on ambiguity. Revenue growth is guided at just 11% to 12%, which is not obviously worth a premium multiple. Informatica integration, FX, and $94 million in Q2 restructuring charges add noise. Some investors may look to Q3 for confirmation that Agentforce is converting bookings into GAAP operating leverage.
What the Numbers Say Right Now
Shares currently trade at $249.12 against an analyst consensus target of $272.13, implying roughly 9% upside. Sentiment is constructive: 6 Strong Buy, 34 Buy, 14 Hold, 0 Sell, and 2 Strong Sell across 56 analysts, with 36 upward EPS revisions for FY27 in the trailing 30 days and zero cuts.
Performance tells a mixed story. CRM is down 5.47% year to date and roughly flat over one year at -0.4%, while the S&P 500 has returned 12.32% YTD and 18.05% over one year. Targets are one input among many, and the gap between fundamentals and price action is unusually wide here.
Why $249 Screens Attractively
At $249.12, the setup for Salesforce looks constructive. Here is why.
The path to appreciation is specific. Agentforce ARR has moved from $500 million to $800 million to $1.2 billion to $1.5 billion in four quarters, and management said ARR is about to cross $4 billion across AI and data. If the second-half reacceleration lands, FY28 EPS estimates near $16.00 understate the operating leverage that Contentful, Fin, and ClaudeForce can unlock.
The catalyst window is short. Dreamforce and Investor Day arrive next week, the ASR settles in October 2026, and Q3 guidance of $11.42 billion to $11.50 billion looks beatable given 14% cRPO growth.
What invalidates the thesis: a Q3 miss on subscription revenue, Agentforce ARR growth slowing below 100% year over year, or GAAP operating margin compressing further. Watch cRPO and net-new AOV quarter by quarter. Underperformance versus the S&P 500 has compressed the risk into an entry price where the AI ramp is nearly free.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
